Evidence map›Paper›PMID 38436275›Full record

ArticleConnective tissue research2024

COL1A1 proximal promoter topology regulates its transcriptional response to transforming growth factor β.

Elena Hitraya, Svetlana Gaidarova, Sonsoles Piera-Velazquez, Sergio A Jimenez

Open access · greenAbstract read
In one paragraph

Article in Connective tissue research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Elena HitrayaJefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Svetlana GaidarovaJefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Sonsoles Piera-VelazquezJefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Sergio A JimenezJefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Jefferson Institute · USFate Therapeutics (United States) · USThomas Jefferson University · US

Funding

BIOCHEMICAL AND VASCULAR ALTERATIONS IN SCLERODERMAR01AR019616 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI JIMENEZ, SERGIO A · 1986 to 2010
$3.2M
NIAMS NIH HHS R01 AR019616
6 · The paper itself

Abstract

objectiveThe COL1A1 proximal promoter contains two GC-rich regions and two inverted CCAAT boxes. The transcription factors Sp1 and CBF bind to the GC sequence at -122 to -115 bp and the inverted CCAAT box at -101 to -96 bp, respectively, and stimulate COL1A1 transcriptional activity.

methodsTo further define the regulatory mechanisms controlling COL1A1 expression by Sp1 and CBF, we introduced 2, 4, 6, or 8 thymidine nucleotides (T-tracts) at position -111 bp of the COL1A1 gene promoter to increase the physical distance between these two binding sites and examined

resultsInsertion of 2 or 4 nucleotides decreased COL1A1 promoter activity by up to 70%. Furthermore, the expected increase in COL1A1 transcription in response to TGF-β1 was abolished. Computer modeling of the modified DNA structure indicated that increasing the physical distance between the Sp1 and CBF binding sites introduces a rotational change in the DNA topology that disrupts the alignment of Sp1 and CBF binding sites and likely alters protein-protein interactions among these transcription factors or their associated co-activators.

conclusionThe topology of the COL1A1 proximal promoter is crucial in determining the transcriptional activity of the gene and its response to the stimulatory effects of TGF-β1.

Indexed as

Transforming Growth Factor betaTransforming Growth Factor beta1DNADNA-Binding ProteinsNucleotidesTranscription FactorsDNADNA-Binding ProteinsNucleotidesTranscription FactorsTransforming Growth Factor betaTransforming Growth Factor beta1CBFCOL1A1 promoterSp1Systemic sclerosisTGF-β1

Identifiers

PMID38436275
PMCPMC10994737
OpenAlexW4392379599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.